All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Cabbage soup is not 'natural Ozempic,' no matter what TikTok says

Tastea Girl

TikTok creator

13.1K viewsWatch on TikTok→

Quick answer

Semaglutide and related GLP-1 receptor agonists produce weight loss and metabolic improvements through direct receptor binding that dietary fiber cannot replicate at comparable magnitude. High-fiber diets modestly stimulate endogenous GLP-1 secretion and improve satiety, but clinical evidence does not support equivalency with pharmaceutical GLP-1 agents for weight management or type 2 diabetes outcomes. Patients considering or currently using GLP-1 medications should not substitute dietary changes based on social media framing without consulting a prescribing clinician.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.

What did @tastea.girl actually say?

The core claim here is simple and stated twice: cabbage soup is "the OG Ozambic" and a reason nobody should need semaglutide. The creator says the soup's fiber will "help me be full for a really long time," and the video is tagged #naturalozempic. So the argument, stripped down, is that dietary fiber from cabbage and vegetables can replicate what a GLP-1 receptor agonist does pharmacologically. That is a significant claim, and it deserves a direct look.

To be fair, the creator is also just sharing a low-calorie vegetable soup recipe with a catchy hashtag. The cooking instructions are sound. The warning about sodium doubling up between bouillon and added salt is genuinely useful advice. But the framing, "why would anybody get Ozempic when this exists," crosses from recipe sharing into medical comparison territory.

Does the science back this up?

No, not in the way the video implies. Fiber does promote satiety, but through completely different mechanisms than GLP-1 receptor agonists. Semaglutide binds GLP-1 receptors in the brain and gut, slowing gastric emptying, suppressing appetite signaling in the hypothalamus, and producing weight loss of 10-15% of body weight in clinical trials (Wilding et al., 2021, NEJM). Cabbage soup does none of that.

What fiber does: soluble fiber ferments in the colon, producing short-chain fatty acids that may modestly stimulate endogenous GLP-1 secretion. A 2019 review by Dahl et al. in the British Journal of Nutrition found that high-fiber diets can raise postprandial GLP-1 levels, but the effect is small and transient, nowhere near the sustained receptor activation from pharmaceutical doses. Cabbage is also predominantly insoluble fiber, which adds bulk and speeds transit but has weaker effects on satiety hormones than soluble fiber sources like oats or legumes.

What did they get wrong (or right)?

Wrong: calling this soup a functional equivalent to Ozempic. That framing is misleading and potentially harmful for people with type 2 diabetes or obesity who might delay or skip treatment based on it. GLP-1 drugs have demonstrated cardiovascular mortality benefits (Marso et al., 2016, NEJM, the LEADER trial). A bowl of cabbage soup has not been tested for those outcomes, because there is no reasonable biological pathway to expect them.

Right: the fiber satiety claim has a real, if limited, basis. Cabbage does contain fiber. A large serving of this soup is low in calories and will occupy stomach volume, which triggers stretch receptors and contributes to fullness. This is a legitimate, evidence-supported mechanism, it just does not make it "Ozempic in soup form."

  • The recipe itself is nutritionally reasonable: low calorie, plant-based, high-vegetable.
  • The sodium warning about bouillon is accurate and practical.
  • The spicy habanero addition is personal preference, not a health mechanism.

What should you actually know?

"Natural Ozempic" is a marketing phrase that has spread across social media with no clinical definition behind it. Foods or supplements labeled this way have not been shown to replicate semaglutide's mechanism or outcomes. If you are on a weight loss journey, a high-fiber, low-calorie diet like this soup genuinely supports that, but through modest, incremental effects, not pharmaceutical-level intervention.

For people managing type 2 diabetes or obesity with significant cardiovascular risk, the decision to use or not use GLP-1 medications should involve a clinician, not a TikTok caption. Dietary changes and medication are not always an either/or choice. Many patients benefit from both. Presenting them as competing options, where the soup "wins," oversimplifies a clinical decision with real health stakes.

The cabbage soup diet itself has been cycling through diet culture since the 1980s. Short-term weight loss from it is real but largely attributable to caloric restriction and water loss, not any unique property of cabbage (Freedman et al., 2001, Obesity Research).

Bottom line

Make the soup. It looks like a reasonable, cheap, filling meal. Ignore the Ozempic comparison entirely. Those are two separate sentences that should never have been in the same video.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksCompounded SemaglutideProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Compounded Semaglutide access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 9 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Cabbage soup is not 'natural Ozempic,' no matter what TikTok says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Compounded Semaglutide is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

Compare providers, services and access requirements in the directory before contacting a suitable care team.

Claim path

Keep researching this semaglutide video claims cluster

Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.

Claim verdict

The useful answer behind this video

Claim being checked

Semaglutide and related GLP-1 receptor agonists produce weight loss and metabolic improvements through direct receptor binding that dietary fiber cannot replicate at comparable magnitude.

FormBlends verdict

Semaglutide and related GLP-1 receptor agonists produce weight loss and metabolic improvements through direct receptor binding that dietary fiber cannot replicate at comparable magnitude. High-fiber diets modestly stimulate endogenous GLP-1 secretion and improve satiety, but clinical evidence does not support equivalency with pharmaceutical GLP-1 agents for weight management or type 2 diabetes outcomes. Patients considering or currently using GLP-1 medications should not substitute dietary changes based on social media framing without consulting a prescribing clinician.

Patient-safe next step

Compare the claim with the Compounded Semaglutide guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Semaglutide and related GLP-1 receptor agonists produce weight loss and metabolic improvements through direct receptor binding that dietary fiber cannot replicate at comparable magnitude. High-fiber diets modestly stimulate endogenous GLP-1 secretion and improve satiety, but clinical evidence does not support equivalency with pharmaceutical GLP-1 agents for weight management or type 2 diabetes outcomes. Patients considering or currently using GLP-1 medications should not substitute dietary changes based on social media framing without consulting a prescribing clinician.
  • Semaglutide produces 10-15% average body weight loss in clinical trials (Wilding et al., 2021, NEJM); no food or soup has been tested against this benchmark.
  • High-fiber diets can modestly raise postprandial GLP-1 levels, but the effect is transient and significantly smaller than pharmaceutical GLP-1 receptor agonism (Dahl et al., 2019, British Journal of Nutrition).

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compounded Semaglutide decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the Compounded Semaglutide guide, cost path, safety notes, and provider review before acting.

Review Compounded Semaglutide

What You'll Learn

  • Semaglutide produces 10-15% average body weight loss in clinical trials (Wilding et al., 2021, NEJM); no food or soup has been tested against this benchmark.
  • High-fiber diets can modestly raise postprandial GLP-1 levels, but the effect is transient and significantly smaller than pharmaceutical GLP-1 receptor agonism (Dahl et al., 2019, British Journal of Nutrition).
  • Cabbage is predominantly insoluble fiber, which adds bulk and supports transit but has weaker satiety hormone effects than soluble fiber sources like oats, beans, or psyllium.
  • The cabbage soup diet has existed since the 1980s; any short-term weight loss is driven by caloric restriction, not a unique biological property of cabbage (Freedman et al., 2001, Obesity Research).
  • GLP-1 medications have demonstrated cardiovascular mortality benefits in high-risk patients (LEADER trial, Marso et al., 2016, NEJM), an outcome class that dietary soup has never been studied for.
  • The 'natural Ozempic' hashtag is a social media phrase with no clinical definition. Regulators and dietitians have repeatedly flagged it as misleading when applied to foods or supplements.
  • One bouillon cube can contribute 700-900mg sodium; combined with added salt and miso, a single serving of this soup could approach or exceed recommended daily sodium limits for some individuals.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Tastea Girl · TikTok creator

13.1K views on this video

Old school healthy ozempic soup. Do you remember when it was viral 10+ years ago? I'm on a weight loss journey #cabbagesoup #tasteagirl #plantbased #viralsoup #naturalozempic

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Tastea Girl, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.